Journal of Operative Dentistry & Endodontics

Register      Login

VOLUME 1 , ISSUE 2 ( July-December, 2016 ) > List of Articles

RESEARCH ARTICLE

Immunological Profile of Periapical and Periodontal Lesions: Current Concepts in the Role of T Cells

KV Arun, Deepavalli Arumuga Nainar, Swarna Alamelu

Citation Information : Arun K, Nainar DA, Alamelu S. Immunological Profile of Periapical and Periodontal Lesions: Current Concepts in the Role of T Cells. J Oper Dent Endod 2016; 1 (2):70-75.

DOI: 10.5005/jp-journals-10047-0015

Published Online: 00-12-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Nainar DA, Alamelu S, Arun KV, Rajasekaran M. Immunological Profile of Periapical and Periodontal Lesions: Current Concepts in the Role of T Cells. J Oper Dent Endod 2016;1(2):70-75.


PDF Share
  1. Oral biofilm-associated diseases: Trends and implications for quality of life, systemic health and expenditures. Periodontol 2000 2011 Feb;55(1):87-103.
  2. Cytokines that promote periodontal tissue destruction. J Periodontol 2008 Aug;79(Suppl 8):1585-1591.
  3. Apical periodontitis: a dynamic encounter between root canal infection and host response. Periodontol 2000 1997 Feb;13(1):121-148.
  4. Review of osteoimmunology and the host response in endodontic and periodontal lesions. J Oral Microbiol 2011 Jan 17;3(suppl).
  5. Periapical inflammatory responses and their modulation. Crit Rev Oral Biol Med 1998;9(4):498-521.
  6. Immune cells in periapical granuloma: Morphological and immunohistochemical characterization. J Endod 1991 Jan;17(1):26-29.
  7. The role of T cells in periodontal disease: Homeostasis and autoimmunity. Periodontol 2000 2007;43:14-40.
  8. Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 2007 Apr;86(4):306-319.
  9. Destructive and protective roles of cytokines in periodontitis: a reappraisal from host defence and tissue destruction viewpoints. J Dent Res 2010 Dec;89(12):1349-1363.
  10. Antigen-presentation and the role of dendritic cells in periodontitis. Periodontol 2000 2004;35(1):135-157.
  11. The lineage decisions of helper T cells. Nat Rev Immunol 2002 Dec;2(12):933-944.
  12. Th1 and Th2 cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol 2001 Aug;22(8):450-457.
  13. Induction of interferon-gamma production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation. Eur J Immunol 1999 Feb;29(2):548-555.
  14. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997 May;89(4):587-596.
  15. Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. Arch Oral Biol 1999 Jan;44(1):55-66.
  16. Periodontitis and arthritis interaction in mice involves a shared hyper-inflammatory genotype and functional immunological interferences. Genes Immun 2010 Sep;11(6):479-489.
  17. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009 Aug;361(9):888-898.
  18. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006 Sep;126(6):1121-1133.
  19. IL-21 and TGF-beta are required for differentiation of human TH17 cells. Nature 2008 Jul;454(7202):350-352.
  20. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003 Jan;278(3):1910-1914.
  21. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin Immunol 2007 Dec;19(6):400-408.
  22. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol 2009 Feb;24(1):1-6.
  23. Interleukin-17 plays a role in exacerbation of inflammation within chronic periapical lesions. Eur J Oral Sci 2007 Aug;115(4):315-320.
  24. An essential role for IL-17 in preventing pathogen initiated bone destruction: Recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007 May;109(9):3794-3802.
  25. IL-17 receptor A signaling is protective in infection-stimulated periapical bone destruction. J Immunol 2013 Aug;191(4):1785-1791.
  26. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970 May;18(5):723-737.
  27. The Th17 lineage: answers to some immunological questions. Immunologia 2009 Jan-Mar;28(1):32-45.
  28. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008 Mar;9(3):239-244.
  29. Conversion of peripheral CD4 + CD25? naive T cells to CD4 + CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003 Dec;198(12):1875-1886.
  30. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum 2007 Dec;56(12):4104-4112.
  31. Production of IL 10 and IL-12 by antigen-presenting cells in periapical lesions. J Oral Pathol Med 2010 Oct;39(9):690-696.
  32. Characterization of CD4+ CD25+ natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. J Leukoc Biol 2008 Jul;84(1):311-318.
  33. Evidence supporting a protective role for th9 and th22 cytokines in human and experimental periapical lesions. J Endod 2013 Jan;39(1):83-87.
  34. Interleukin-22 producing T cells: a specialized population involved in skin inflammation? Immunol Cell Biol 2009 Sep;87:574-576.
  35. Simultaneous analysis of T helper subsets (Th1, Th2, Th9, Th17, Th22, Tfh, Tr1 and Tregs) markers expression in periapical lesions reveals multiple cytokine clusters accountable for lesions activity and inactivity status. J Appl Oral Sci 2014 Jul-Aug;22(4):336-346.
  36. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol 2007 Dec;150(3):407-415.
  37. The promotional effect of IL 22 on mineralization activity of periodontal ligament cells. Cytokine 2012 Jul;59(1):41-48.
  38. Transforming growth factor beta “reprograms” the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008 Dec;9(12):1341-1346.
  39. IL-9: Basic biology, signalling pathways in CD4+ T cells and implications for autoimmunity. J Neuroimmune Pharmacol 2010 Jun;5(2):198-209.
  40. The Th17 pathway and inflammatory diseases of the intestines, lungs and skin. Annu Rev Pathol 2013 Jan;8:477-512.
  41. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-852.
  42. Interleukin-17 family members and inflammation. Immunity 2004 Oct;21(4):467-476.
  43. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012 Oct;11(10):763-776.
  44. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011 May;12(5):383-390.
  45. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009;458(7236):351-356.
  46. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006 Aug;212:8-27.
  47. Regulatory T cells in mouse periapical lesions. J Endod 2009 Sep;35(9):1229-1233.
  48. The potential role of suppressors of cytokine signaling in the attenuation of inflammatory reaction and alveolar bone loss associated with apical periodontitis. J Endod 2008 Dec;34(12):1480-1484.
  49. Regulatory T-cells infiltrate periodontal disease tissues. J Dent Res 2005 Jul;84(7):639-643.
  50. Reciprocal development pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 May;441(7090):235-238.
  51. After TH1/TH2 now comes Treg/TH17: Significance of T helper cells in immune response organization. Hautarzt 2006 Aug;57(8):730-732.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.